Analyst firms · Leerink Partners · ITOS

Leerink Partners ITOS price target and rating history

iTeos Therapeutics Inc. (ITOS) · Health Care

Leerink Partners rates iTeos Therapeutics Inc. (ITOS) Market Perform with a $9 price target, as of its latest action on May 14, 2025. It has published 3 rating actions on ITOS since August 2021, including 0 upgrades and 1 downgrade.

Current rating
Market Perform
Price target
$9
Median target, all firms
Too few
Actions on ITOS
3

Leerink Partners price target on ITOS

$55$32$920222023202420252026
Leerink Partners price target on ITOS, each point a stated target, August 2021 to May 2025.

Every Leerink Partners rating on ITOS

Questions about Leerink Partners and ITOS

What is Leerink Partners's price target for ITOS?
Leerink Partners's latest stated price target for iTeos Therapeutics Inc. (ITOS) is $9, from its action on May 14, 2025.
What is Leerink Partners's rating on ITOS?
Leerink Partners rates ITOS Market Perform, a neutral rating, as of May 14, 2025.
When did Leerink Partners last change its view on ITOS?
On May 14, 2025, Leerink Partners downgrades to Market Perform from Outperform, price target $9.

All Leerink Partners ratingsITOS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.